US AUTHORITIES have granted approval for a unique new medical device - a toilet seat which can automatically monitor users' vital signs.
The new Heart Seat (pictured), manufactured by Casana, is able to measure heart rate and oxygen saturation, with enhancements for additional clinical measurements currently in the process of validation, including systolic and diastolic blood pressure.
"When used, the system unobtrusively gathers health data and analyses it in context to provide insights into health and trends over time," the company said.
Data collated is automatically sent to an online "dashboard" accessible by a designated care team, with the aim of providing health professionals with "reliable, clear trends within real-life context".
Casana CEO Ausin McChord said the Food and Drug Administration approval was a "critical step on our journey to commercialise the Heart Seat".
"This brings us one step closer to helping patients and healthcare providers across the US manage their health at home," he added.
The Heart Seat is expected to launch by the end of 2023.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 May 23
